According to a new report by UnivDatos, The premenstrual syndrome treatment market is expected to reach USD million in 2033 by growing at a CAGR of 4.74%. Premenstrual Syndrome (PMS) has substantial economic and healthcare implications that extend beyond individual discomfort. Millions of women around the world face symptoms that impact concentration, lower productivity, and...